Leading oxygen concentrator manufacturers Yuwell Medical and Inogen have announced an investment tie up to advance their medical device and respiratory businesses.
Yuwell, through its whole-owned subsidiary Yuwell (Hong Kong) Holdings, has agreed to invest approximately $27.2m in Inogen, representing 9.9% of the outstanding shares of Inogen’s common stock.
The memorandum, announced at Arab Health in Dubai, unites two of the major players in the China and US respiratory health sectors.
Both companies agree to carry out in-depth strategic cooperation based on business synergy in international distribution business, trademark licensing and distribution business, joint research and development, and supply chain optimisation.
Alex WU, Chairman of Yuwell Medical, said it aims to become one of the top three companies in the global home medical health market in the mid-to-long term and it will work “hand in hand” with global partners to provide users with more competitive products and better health solutions.
The exhibition, marking its 50th edition, has attracted participants from over 180 countries. The Arab Health Congress also returns this year, featuring nine continuing medical education (CME) conferences and three Healthcare Business Forums.
The consumer healthcare market, valued at $360bn in 2023, is projected to reach $780bn by 2030, according to Verified Market Research.
